Details of the Drug
General Information of Drug (ID: DM4FJHO)
| Drug Name |
(5-Methoxy-chroman-3-yl)-dipropyl-amine
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
5-Meo-dpac; 5-Methoxy-3-(di-n-propylamino)chroman; CHEMBL283606; 3-Dipropylamino-5-methyloxychroman; 5-Methoxy-3-(dipropylamino)chroman; (5-Methoxy-chroman-3-yl)-dipropyl-amine; AC1MIZ4R; 110927-00-9; SCHEMBL2217080; CTK8G5655; GOWYIQOIWRLZLO-UHFFFAOYSA-N; BDBM50036862; 3-(Di-n-propylamino)-5-methoxychroman; L023817; 5-methoxy-N,N-dipropyl-3,4-dihydro-2H-chromen-3-amine; 5-methoxy-3,4-dihydro-N,N-dipropyl-2H-[1]-benzopyran-3-amine; 2H-1-Benzopyran-3-amine, 3,4-dihydro-5-methoxy-N,N-dipropyl-
|
||||||||||||||||||
| Indication |
|
||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 263.37 | |||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 3.8 | ||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 6 | ||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 0 | ||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 3 | ||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Discovery agent | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||
|
||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||


